Shares of Valiant Organics gained 4 per cent to Rs 3,454 on the BSE on Monday, in an otherwise subdued market, ahead of turning ex-date on Thursday, December 24, 2020 for its 1:1 bonus issue. Stock of the pharmaceutical company has rallied 13 per cent in the past eight trading days.
The Company has fixed December 28, 2020 as the 'Record Date' to determine the eligible shareholders entitled to receive the bonus shares. The board of directors of the company on November 13, 2020 had recommended the issue of bonus shares in the ratio of 1:1 i.e. 1 bonus equity share for 1 equity share held in the company as on record date.
In the past three months, the stock has underperformed the market by gaining 20 per cent, as compared to a 23-per cent rise in the S&P BSE Sensex. It hit a record high of Rs 3,851 on November 5, 2020.
Valiant Organics is one of the most competitive producers of Chlorination, Ammonolysis, Acetylation, Hydrogenation and Methoxylationbased specialty products in India.
The company has increased the capacities of its hydrogenation products from the earlier 18,000 MT per annum to 26,000 MT per annum. Further, it increased the Ammonolysis capacity at Tarapur and Vapi plants from ~13,000 MT per annum to 16,000 MT per annum.
The management said the company is likely to commence operations of Para Amino Phenol (PAP) and Ortho Amino Phenol (OAP), which are import substitutes, in the second half of FY 2020-21. PAP has been identified as key intermediates of pharma products by the government, which is to be incentivised under recently announced PLI Scheme. The management is considering setting up a plant for Paracetamol with other drug intermediates and APIs in future.
On outlook, the management, in fiscal 2019-20 annual report, said the company is well prepared to take advantage of the growing opportunities in specialty chemicals as India's specialty chemicals market sets itself on the growth path for the coming years, and with a rising need for specialty chemicals in the end-use domestic markets.
"As we add specialty chemicals to our portfolio and continually update our product mix, we remain well positioned to capture this growth and become a leading specialty chemicals player in India, delivering sustainable stakeholder growth," it said.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU